MIR4651: A Drug Target / Disease Biomarker (G100616270)
MIR4651: A Drug Target / Disease Biomarker
MIR4651, also known as interleukin-4651, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes proteins that play a crucial role in the regulation of immune and inflammatory responses. MIR4651 has been shown to have a variety of functions, including the regulation of inflammation, immune cell function, and tissue repair. As a result, MIR4651 has potential as a drug target or biomarker for a variety of diseases.
One of the key functions of MIR4651 is its role in the regulation of inflammation. MIR4651 has been shown to play a key role in the regulation of the inflammatory response by suppressing the activity of immune cells such as T cells and N cells. This is accomplished through the regulation of the activity of several intracellular signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These signaling pathways are involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. By suppressing the activity of these pathways, MIR4651 helps to prevent the excessive activation and proliferation of immune cells, which can lead to the development of inflammatory diseases such as rheumatoid arthritis, asthma, and cancer.
Another function of MIR4651 is its role in the regulation of immune cell function. MIR4651 has been shown to play a key role in the regulation of T cell function by regulating the activity of the transcription factor TGF-β. This is accomplished through the regulation of the activity of the kinase PDK4, which is involved in the translation of TGF-β messages into tyrosine. MIR4651 has been shown to inhibit the activity of PDK4, which leads to the suppression of TGF-β signaling and the regulation of T cell function.
In addition to its role in the regulation of inflammation and immune cell function, MIR4651 has also been shown to play a key role in the regulation of tissue repair. MIR4651 has been shown to play a key role in the regulation of the cell proliferation and differentiation of progenitor cells, which are responsible for the development and repair of damaged tissue. This is accomplished through the regulation of several intracellular signaling pathways, including the TGF-β pathway and the Wnt pathway. These signaling pathways are involved in the regulation of cellular processes such as cell growth, differentiation, and angiogenesis. By regulating the activity of these pathways, MIR4651 helps to ensure the proper development and repair of damaged tissue, which is important for the maintenance of overall cellular health and the prevention of diseases such as cancer.
Given its variety of functions, MIR4651 has significant potential as a drug target or biomarker for a variety of diseases. For example, MIR4651 has been shown to be a potential therapeutic for the treatment of rheumatoid arthritis by regulating the activity of immune cells. Additionally, MIR4651 has been shown to be a potential biomarker for the diagnosis of cancer by regulating the activity of immune cells.
In conclusion, MIR4651 is a protein that plays a crucial role in the regulation of inflammation, immune cell function, and tissue repair. Its functions make it an attractive target for the development of new drugs or biomarkers for the treatment of a variety of diseases. Further research is needed to fully understand the role of MIR4651 in these processes and to develop effective treatments based on this protein.
Protein Name: MicroRNA 4651
The "MIR4651 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4651 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757
